https://www.selleckchem.com/pr....oducts/p5091-p005091
3 months. After adjustment for age, sex, and comorbidities, RM was associated with a lower risk of death (hazard ratio [HR] 0.43, 95% confidence interval [CI] 0.36-0.52; P 0.001) and CV hospitalization (HR 0.76, 95% CI 0.64-0.91; P= 0.002). In the economic model, cost savings were observed over 5 years with an estimated savings of $12,195 per person (95% CI-$21,818 to-$4,79. The model estimated a cost-savings associated with RM strategy in 99% of simulations. These population data support more widespread implementation of R